KRAS Mutation-Related Tumors trials recruiting in California

Fewer than 3 recruiting trials found.

All KRAS Mutation-Related Tumors trials nationally

Cities in California

Recruiting trials in California

• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
  NCT05786924 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Los Angeles, San Francisco
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
  NCT07064018 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Orange